http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2528342-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a703695f605ded296e3ff7b8bb45ea88 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-225 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-225 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
| filingDate | 2015-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e96bd37d75bee32f821e10d1572eb37c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d01ac01792ce7e42ed114898610120a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b68db1f5ba23fb94fe2bb1b7acf318af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67cc917a7f433a9753c03129f061fda3 |
| publicationDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-2528342-A |
| titleOfInvention | Lactobacillus strain, composition and use thereof for treating syndromes and related complications of autoimmune diseases |
| abstract | The invention relates to a isolated strain of Lactobacillus species for treating a syndrome and a complication of an autoimmune disease, and the isolated strain of the Lactobacillus species is at least one selected from the group consisting of Lactobacillus paracasei strain GMNL-32 (GM-080), Lactobacillus reuteri strain GMNL-89, Lactobacillus reuteri GMNL-263 and any combinations thereof. The invention may relate to a lactic acid bacteria (LAB) strain used for preparation of medical compositions for treating a syndrome and a complication of an autoimmune disease, the compositions comprising an effective amount of a LAB strain and a pharmaceutically acceptable carrier. The invention may relate to associated LAB-containing compositions, and methods of treating a syndrome and a related complication of an autoimmune disease comprising administering LAB-containing compositions. Preferably, the autoimmune disease is systemic lupus erythematosus (SLE) and the related complication is a cardiac and hepatic disease induced by the autoimmune diseases. |
| priorityDate | 2014-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 162.